Literature DB >> 18561198

Use of CD137 to study the full repertoire of CD8+ T cells without the need to know epitope specificities.

Matthias Wölfl1, Jürgen Kuball, Matthias Eyrich, Paul G Schlegel, Philip D Greenberg.   

Abstract

CD137 (4-1BB) is a member of the TNFR-family with costimulatory function, triggering prosurvival signals in activated T-cells. Upregulation of CD137 upon stimulation allows identifying and isolating live, human antigen-specific CD8+ T-cells of all phenotypes, and therefore provides a comprehensive detection method. Furthermore responses against antigen mixtures can be easily detected, enabling antigen discovery in a stepwise deconvoluting approach. In this article, we will discuss various aspects of this methodology, including potential pitfalls as well as a variety of applications, as illustrated by examples from our laboratory.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18561198      PMCID: PMC2784669          DOI: 10.1002/cyto.a.20594

Source DB:  PubMed          Journal:  Cytometry A        ISSN: 1552-4922            Impact factor:   4.355


  30 in total

1.  Host T cells resist graft-versus-host disease mediated by donor leukocyte infusions.

Authors:  B R Blazar; C J Lees; P J Martin; R J Noelle; B Kwon; W Murphy; P A Taylor
Journal:  J Immunol       Date:  2000-11-01       Impact factor: 5.422

Review 2.  Adoptive immunotherapy: engineering T cell responses as biologic weapons for tumor mass destruction.

Authors:  William Y Ho; Joseph N Blattman; Michelle L Dossett; Cassian Yee; Philip D Greenberg
Journal:  Cancer Cell       Date:  2003-05       Impact factor: 31.743

3.  Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation.

Authors:  Michael R Betts; Jason M Brenchley; David A Price; Stephen C De Rosa; Daniel C Douek; Mario Roederer; Richard A Koup
Journal:  J Immunol Methods       Date:  2003-10-01       Impact factor: 2.303

4.  Regulation of melanoma epitope-specific cytolytic T lymphocyte response by immature and activated dendritic cells, in vitro.

Authors:  Shikhar Mehrotra; Robert Stevens; Ryan Zengou; Nitya G Chakraborty; Lisa H Butterfield; James S Economou; David I Dorsky; Bijay Mukherji
Journal:  Cancer Res       Date:  2003-09-01       Impact factor: 12.701

5.  Standardization and optimization of multiparameter intracellular cytokine staining.

Authors:  Laurel Nomura; Vernon C Maino; Holden T Maecker
Journal:  Cytometry A       Date:  2008-11       Impact factor: 4.355

6.  4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function.

Authors:  Tao Wen; Jacob Bukczynski; Tania H Watts
Journal:  J Immunol       Date:  2002-05-15       Impact factor: 5.422

7.  In vivo stimulation of CD137 broadens primary antiviral CD8+ T cell responses.

Authors:  E Scott Halstead; Yvonne M Mueller; John D Altman; Peter D Katsikis
Journal:  Nat Immunol       Date:  2002-05-20       Impact factor: 25.606

8.  Selective depletion of donor alloreactive T cells without loss of antiviral or antileukemic responses.

Authors:  Persis J Amrolia; Giada Muccioli-Casadei; Eric Yvon; Helen Huls; Uluhan Sili; Eric D Wieder; Catherine Bollard; Jaroslav Michalek; Victor Ghetie; Helen E Heslop; Jeffrey J Molldrem; Cliona M Rooney; John Schlinder; Ellen Vitetta; Malcolm K Brenner
Journal:  Blood       Date:  2003-05-22       Impact factor: 22.113

9.  Expression and function of 4-1BB during CD4 versus CD8 T cell responses in vivo.

Authors:  Wojciech Dawicki; Tania H Watts
Journal:  Eur J Immunol       Date:  2004-03       Impact factor: 5.532

10.  4-1BB promotes the survival of CD8+ T lymphocytes by increasing expression of Bcl-xL and Bfl-1.

Authors:  Hyeon-Woo Lee; Su-Jung Park; Beom K Choi; Hyun Hwa Kim; Kyung-Ok Nam; Byoung S Kwon
Journal:  J Immunol       Date:  2002-11-01       Impact factor: 5.422

View more
  29 in total

1.  Clinical and Immunologic Biomarkers for Histologic Regression of High-Grade Cervical Dysplasia and Clearance of HPV16 and HPV18 after Immunotherapy.

Authors:  Matthew P Morrow; Kimberly A Kraynyak; Cornelia L Trimble; Mark L Bagarazzi; Albert J Sylvester; Michael Dallas; Dawson Knoblock; Jean D Boyer; Jian Yan; Russell Vang; Amir S Khan; Laurent Humeau; Niranjan Y Sardesai; J Joseph Kim; Stanley Plotkin; David B Weiner
Journal:  Clin Cancer Res       Date:  2017-10-30       Impact factor: 12.531

2.  Recombinant Adenovirus Expressing a Soluble Fusion Protein PD-1/CD137L Subverts the Suppression of CD8+ T Cells in HCC.

Authors:  Yonghui Zhang; Hailin Zhang; Mei Wei; Tao Mou; Tao Shi; Yanyu Ma; Xinyu Cai; Yunzheng Li; Jie Dong; Jiwu Wei
Journal:  Mol Ther       Date:  2019-08-05       Impact factor: 11.454

3.  Cross-presentation and genome-wide screening reveal candidate T cells antigens for a herpes simplex virus type 1 vaccine.

Authors:  Lichen Jing; Jürgen Haas; Tiana M Chong; Joseph J Bruckner; Greg C Dann; Lichun Dong; Joshua O Marshak; Christopher L McClurkan; Tori N Yamamoto; Susanne M Bailer; Kerry J Laing; Anna Wald; Georges M G M Verjans; David M Koelle
Journal:  J Clin Invest       Date:  2012-01-03       Impact factor: 14.808

4.  MVA vaccine encoding CMV antigens safely induces durable expansion of CMV-specific T cells in healthy adults.

Authors:  Corinna La Rosa; Jeff Longmate; Joy Martinez; Qiao Zhou; Teodora I Kaltcheva; Weimin Tsai; Jennifer Drake; Mary Carroll; Felix Wussow; Flavia Chiuppesi; Nicola Hardwick; Sanjeet Dadwal; Ibrahim Aldoss; Ryotaro Nakamura; John A Zaia; Don J Diamond
Journal:  Blood       Date:  2016-10-19       Impact factor: 22.113

5.  Detection and preliminary characterization of CD8+T lymphocytes specific for Wilms' tumor antigen in patients with non-Hodgkin lymphoma.

Authors:  Anna Israyelyan; Corinna La Rosa; Weimin Tsai; Teodora Kaltcheva; Tumul Srivastava; Lia Aquino; Jianqiang Li; Young Kim; Joycelynne Palmer; Leanne Streja; David Senitzer; John A Zaia; Andreas Rosenwald; Stephen J Forman; Ryotaro Nakamura; Don J Diamond
Journal:  Leuk Lymphoma       Date:  2013-04-30

6.  Proteome-Wide Zika Virus CD4 T Cell Epitope and HLA Restriction Determination.

Authors:  Victoria L Campbell; LeAnn Nguyen; Elise Snoey; Christopher L McClurkan; Kerry J Laing; Lichun Dong; Alessandro Sette; Cecilia S Lindestam Arlehamn; Danny M Altmann; Rosemary J Boyton; Justin A Roby; Michael Gale; Mars Stone; Michael P Busch; Phillip J Norris; David M Koelle
Journal:  Immunohorizons       Date:  2020-08-04

7.  Synthetic consensus HIV-1 DNA induces potent cellular immune responses and synthesis of granzyme B, perforin in HIV infected individuals.

Authors:  Matthew P Morrow; Pablo Tebas; Jian Yan; Lorenzo Ramirez; Anna Slager; Kim Kraynyak; Malissa Diehl; Divya Shah; Amir Khan; Jessica Lee; Jean Boyer; J Joseph Kim; Niranjan Y Sardesai; David B Weiner; Mark L Bagarazzi
Journal:  Mol Ther       Date:  2014-12-22       Impact factor: 11.454

8.  Measuring antigen-specific immune responses, 2008 update.

Authors:  Jan W Gratama; Florian Kern; Fabrizio Manca; Mario Roederer
Journal:  Cytometry A       Date:  2008-11       Impact factor: 4.355

9.  Activation-induced CD137 is a fast assay for identification and multi-parameter flow cytometric analysis of alloreactive T cells.

Authors:  N H R Litjens; E A de Wit; C C Baan; M G H Betjes
Journal:  Clin Exp Immunol       Date:  2013-10       Impact factor: 4.330

10.  Diverse specificities, phenotypes, and antiviral activities of cytomegalovirus-specific CD8+ T cells.

Authors:  S E Jackson; G M Mason; G Okecha; J G P Sissons; M R Wills
Journal:  J Virol       Date:  2014-07-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.